MetaADEDB 2.0 @ LMMD
Buprenorphine, Naloxone Drug Combination
(SFNLWIKOKQVFPB-KZCPYJDTSA-N)
Structure
SMILES
CO[C@]12CC[C@]3(C[C@@H]1[C@@](C(C)(C)C)(O)C)[C@@]14[C@H]2Oc2c4c(C[C@H]3N(CC1)CC1CC1)ccc2O.C=CCN1CC[C@@]23[C@@]4([C@H]1Cc1c3c(O[C@H]2C(=O)CC4)c(cc1)O)O
Molecular Formula:
C48H62N2O8
Molecular Weight:
795.014
Log P:
5.5910
Hydrogen Bond Acceptor:
10
Hydrogen Bond Donor:
4
TPSA:
132.16
CAS Number(s):
352020-56-5
Synonym(s)
1.
Buprenorphine, Naloxone Drug Combination
2.
Buprenorphine Naloxone
3.
Buprenorphine Naloxone Drug Combination
4.
Buprenorphine-Naloxone
5.
Buprenorphine-Naloxone Combination
6.
Buprenorphine-Naloxone Drug Combination
7.
Suboxone
8.
Buprenorphine Naloxone Combination
9.
Combination, Buprenorphine-Naloxone
10.
Combination, Buprenorphine-Naloxone Drug
11.
Drug Combination, Buprenorphine-Naloxone
12.
Naloxone, Buprenorphine
External Link(s)
MeSHD000069479
PubChem Compound11274356
Adverse Drug Event(s)
NameNumber of ReportsReference(s)Data Source
1NauseaFAERS: 90US FAERS
2Drug ineffectiveFAERS: 67US FAERS
3VomitingFAERS: 60US FAERS
4HeadacheFAERS: 56US FAERS
5Drug withdrawal syndromeFAERS: 43US FAERS
6Product substitution issueFAERS: 43US FAERS
7MalaiseFAERS: 36US FAERS
8Product adhesion issueFAERS: 33US FAERS
9Wrong technique in product usage processFAERS: 29US FAERS
10Drug DependenceFAERS: 27US FAERS
11Product solubility abnormalFAERS: 26US FAERS
12Oral administration complicationFAERS: 22US FAERS
13PainFAERS: 21US FAERS
14Drug effect incompleteFAERS: 20US FAERS
15Product physical consistency issueFAERS: 20US FAERS
16Feeling abnormalFAERS: 19US FAERS
17TremorFAERS: 18US FAERS
18AnxietyFAERS: 17US FAERS
19DizzinessFAERS: 17US FAERS
20Product quality issueFAERS: 17US FAERS
21AstheniaFAERS: 16US FAERS
22ConstipationFAERS: 13US FAERS
23FatigueFAERS: 13US FAERS
24StomatitisFAERS: 13US FAERS
25Accidental exposure to product by childFAERS: 10US FAERS
26Intentional product use issueFAERS: 10US FAERS
27Product distribution issueFAERS: 10US FAERS
28UrticariaFAERS: 10US FAERS
29LethargyFAERS: 9US FAERS
30Therapy changeFAERS: 9US FAERS
31ChillsFAERS: 8US FAERS
32EndocarditisFAERS: 8US FAERS
33OverdoseFAERS: 8US FAERS
34PruritusFAERS: 8US FAERS
35SomnolenceFAERS: 8US FAERS
36Abdominal discomfortFAERS: 7US FAERS
37Drug ineffective for unapproved indicationFAERS: 7US FAERS
38MyalgiaFAERS: 7US FAERS
39PalpitationsFAERS: 7US FAERS
40RestlessnessFAERS: 7US FAERS
41Drug administration errorFAERS: 6US FAERS
42Drug diversionFAERS: 6US FAERS
43Abdominal PainFAERS: 5US FAERS
44Drug abuseFAERS: 5US FAERS
45HypersensitivityFAERS: 5US FAERS
46Incorrect route of drug administrationFAERS: 5US FAERS
47Limb discomfortFAERS: 5US FAERS
48Medication ErrorFAERS: 5US FAERS
49Restless Legs SyndromeFAERS: 5US FAERS
50Toxicity to various agentsFAERS: 5US FAERS
51Accidental overdoseFAERS: 4US FAERS
52AmnesiaFAERS: 4US FAERS
53AngerFAERS: 4US FAERS
54Cold sweatFAERS: 4US FAERS
55CryingFAERS: 4US FAERS
56DependenceFAERS: 4US FAERS
57DysuriaFAERS: 4US FAERS
58NervousnessFAERS: 4US FAERS
59Product dosage form issueFAERS: 4US FAERS
60Product use in unapproved indicationFAERS: 4US FAERS
61Pulmonary EmbolismFAERS: 4US FAERS
62Therapeutic response unexpectedFAERS: 4US FAERS
63Unevaluable eventFAERS: 4US FAERS
64ApathyFAERS: 3US FAERS
65Back PainFAERS: 3US FAERS
66CellulitisFAERS: 3US FAERS
67Chest PainFAERS: 3US FAERS
68DiscomfortFAERS: 3US FAERS
69Drug dose omissionFAERS: 3US FAERS
70Drug effect variableFAERS: 3US FAERS
71HypersomniaFAERS: 3US FAERS
72Night sweatsFAERS: 3US FAERS
73OsteomyelitisFAERS: 3US FAERS
74Peripheral swellingFAERS: 3US FAERS
75Product packaging issueFAERS: 3US FAERS
76Product use issueFAERS: 3US FAERS
77RetchingFAERS: 3US FAERS
78SwellingFAERS: 3US FAERS
79SyncopeFAERS: 3US FAERS
80Unresponsive to stimuliFAERS: 3US FAERS
81treatment failureFAERS: 3US FAERS
82AbscessFAERS: 2US FAERS
83Adverse eventFAERS: 2US FAERS
84ArthralgiaFAERS: 2US FAERS
85Burning sensationFAERS: 2US FAERS
86Cerebrovascular accidentFAERS: 2US FAERS
87Dental cariesFAERS: 2US FAERS
88Depressed Level of ConsciousnessFAERS: 2US FAERS
89Disease recurrenceFAERS: 2US FAERS
90Drug ToleranceFAERS: 2US FAERS
91Drug dispensing errorFAERS: 2US FAERS
92Drug effect delayedFAERS: 2US FAERS
93Drug screen positiveFAERS: 2US FAERS
94DysarthriaFAERS: 2US FAERS
95DysgeusiaFAERS: 2US FAERS
96DyspepsiaFAERS: 2US FAERS
97Economic problemFAERS: 2US FAERS
98Eye painFAERS: 2US FAERS
99Feeling jitteryFAERS: 2US FAERS
100GlossitisFAERS: 2US FAERS
101Incorrect dose administeredFAERS: 2US FAERS
102InfluenzaFAERS: 2US FAERS
103Insurance issueFAERS: 2US FAERS
104Intentional product misuseFAERS: 2US FAERS
105PhotophobiaFAERS: 2US FAERS
106Prescription drug used without a prescriptionFAERS: 2US FAERS
107Product barcode issueFAERS: 2US FAERS
108Product formulation issueFAERS: 2US FAERS
109Product taste abnormalFAERS: 2US FAERS
110Pulmonary sepsisFAERS: 2US FAERS
111Respiratory DepressionFAERS: 2US FAERS
112Septic embolusFAERS: 2US FAERS
113Sexual DysfunctionFAERS: 2US FAERS
114SneezingFAERS: 2US FAERS
115Tongue blisteringFAERS: 2US FAERS
116Tongue discomfortFAERS: 2US FAERS
117Urinary RetentionFAERS: 2US FAERS
118Visual ImpairmentFAERS: 2US FAERS
119Weight decreasedFAERS: 2US FAERS
120Abdominal tendernessFAERS: 1US FAERS
121AcneFAERS: 1US FAERS
122Activities of daily living impairedFAERS: 1US FAERS
123AgeusiaFAERS: 1US FAERS
124AgitationFAERS: 1US FAERS
125Alcohol IntoleranceFAERS: 1US FAERS
126Alcohol interactionFAERS: 1US FAERS
127Altered state of consciousnessFAERS: 1US FAERS
128AphagiaFAERS: 1US FAERS
129BedriddenFAERS: 1US FAERS
130Blood testosterone decreasedFAERS: 1US FAERS
131Bone painFAERS: 1US FAERS
132Chest discomfortFAERS: 1US FAERS
133Cluster HeadacheFAERS: 1US FAERS
134Completed SuicideFAERS: 1US FAERS
135Depressed moodFAERS: 1US FAERS
136DisorientationFAERS: 1US FAERS
137Documented hypersensitivity to administered productFAERS: 1US FAERS
138Drug level below therapeuticFAERS: 1US FAERS
139Drug prescribing errorFAERS: 1US FAERS
140Drug screen false positiveFAERS: 1US FAERS
141Drug screen negativeFAERS: 1US FAERS
142Drug withdrawal headacheFAERS: 1US FAERS
143Ear discomfortFAERS: 1US FAERS
144Eating disorder symptomFAERS: 1US FAERS
145EczemaFAERS: 1US FAERS
146Emotional disorderFAERS: 1US FAERS
147EncephalitisFAERS: 1US FAERS
148Erectile dysfunctionFAERS: 1US FAERS
149Euphoric moodFAERS: 1US FAERS
150Exposure during breast feedingFAERS: 1US FAERS
151Extra dose administeredFAERS: 1US FAERS
152FasciotomyFAERS: 1US FAERS
153Feeling ColdFAERS: 1US FAERS
154Feeling of body temperature changeFAERS: 1US FAERS
155FormicationFAERS: 1US FAERS
156Gastric ulcerFAERS: 1US FAERS
157Hepatitis C virus test positiveFAERS: 1US FAERS
158HyperacusisFAERS: 1US FAERS
159HypogonadismFAERS: 1US FAERS
160Inappropriate schedule of drug administrationFAERS: 1US FAERS
161Incorrect product storageFAERS: 1US FAERS
162Incorrect route of product administrationFAERS: 1US FAERS
163Intercepted product dispensing errorFAERS: 1US FAERS
164LazinessFAERS: 1US FAERS
165Lip swellingFAERS: 1US FAERS
166Loss of personal independence in daily activitiesFAERS: 1US FAERS
167Memory impairmentFAERS: 1US FAERS
168Mental impairmentFAERS: 1US FAERS
169MonoplegiaFAERS: 1US FAERS
170Mood swingsFAERS: 1US FAERS
171Mouth swellingFAERS: 1US FAERS
172Muscle FatigueFAERS: 1US FAERS
173NasopharyngitisFAERS: 1US FAERS
174Neonatal complications of substance abuseFAERS: 1US FAERS
175Oral candidiasisFAERS: 1US FAERS
176Oropharyngeal blisteringFAERS: 1US FAERS
177Penile curvatureFAERS: 1US FAERS
178Poor quality sleepFAERS: 1US FAERS
179Product container seal issueFAERS: 1US FAERS
180Product dispensing errorFAERS: 1US FAERS
181Product dose omissionFAERS: 1US FAERS
182Product packaging quantity issueFAERS: 1US FAERS
183Product physical issueFAERS: 1US FAERS
184Product preparation errorFAERS: 1US FAERS
185Pupillary light reflex tests abnormalFAERS: 1US FAERS
186Rash erythematousFAERS: 1US FAERS
187Reaction to excipientFAERS: 1US FAERS
188Seasonal Affective DisorderFAERS: 1US FAERS
189Similar reaction on previous exposure to drugFAERS: 1US FAERS
190Skin irritationFAERS: 1US FAERS
191Suppressed lactationFAERS: 1US FAERS
192Swelling of eyelidFAERS: 1US FAERS
193TachycardiaFAERS: 1US FAERS
194Terminal dribblingFAERS: 1US FAERS
195Therapeutic product effect decreasedFAERS: 1US FAERS
196Therapeutic product effect incompleteFAERS: 1US FAERS
197Therapy cessationFAERS: 1US FAERS
198Tongue movement disturbanceFAERS: 1US FAERS
199Tooth LossFAERS: 1US FAERS
200Urinary tract infectionFAERS: 1US FAERS
201WheezingFAERS: 1US FAERS
202Heroin Dependence19948382CTD
203Morphine Dependence21270789CTD
204Opioid-Related Disorders17517480
17565668
CTD
205Pain, Postoperative19448245CTD
206Substance Withdrawal Syndrome21270789CTD
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120239

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.